文献速递心脑血管急症重症综合管理与镇静镇痛

星状神经节阻滞与动脉内解痉治疗脑血管痉挛:回顾性队列研究

Stellate Ganglion Block and Intraarterial Spasmolysis in Patients with Cerebral Vasospasm: A Retrospective Cohort Study.
PubMed 文献 · Neurocrit Care · 2023-07-27
一句话结论对动脉瘤性蛛网膜下腔出血后症状性脑血管痉挛,CBFV<180 cm/s 时作者建议单用星状神经节阻滞,≥180 cm/s 时升级动脉内解痉可能获益。

本回顾性队列纳入2012至2021年动脉瘤性蛛网膜下腔出血后脑血管痉挛、接受星状神经节阻滞(SGB)或动脉内解痉(IAS)的患者82例、184个治疗区域,并提取109个未受累区域作对照。在平均脑血流速度(CBFV)≥120 cm/s且诱导性高血压下仍有持续神经功能恶化/需插管时行挽救治疗。次日大脑中动脉平均CBFV分别下降:SGB组-30.1(±45.2)cm/s,IAS组-31.5(±45.2)cm/s;混合线性回归显示治疗类别有统计学意义,性别、年龄、动脉瘤治疗方式、WFNS评分和Fisher评分等固定效应无统计学意义。Logistic回归显示ICU出院前影像学脑梗死(34/82)与随访时不良结局(GOS≤3)显著相关。作者建议轻度症状性CV(CBFV<180 cm/s)单用SGB,难治性CV且CBFV≥180 cm/s时升级IAS有益。

要点

  • 挽救治疗启动条件:平均CBFV≥120 cm/s,且在诱导性高血压下仍持续神经功能恶化或需插管。
  • 次日大脑中动脉平均CBFV下降:SGB组-30.1(±45.2)cm/s,IAS组-31.5(±45.2)cm/s。
  • 混合线性回归显示治疗类别有统计学意义,性别、年龄、动脉瘤治疗方式(夹闭或栓塞)、WFNS评分、Fisher评分等固定效应无统计学意义。
  • ICU出院前影像学脑梗死34/82例,与随访时不良结局(GOS≤3)显著相关。
  • 作者建议:轻度症状性CV(CBFV<180 cm/s)单用SGB;难治性CV且CBFV≥180 cm/s时升级IAS可能有益。

适用人群与场景

  • 动脉瘤性蛛网膜下腔出血后发生脑血管痉挛的患者,来自2012至2021年的回顾性分析。
  • 纳入接受SGB或IAS治疗的患者;共82例、184个治疗区域,另提取109个未受累区域作为对照。

诊断标准与关键阈值

  • 挽救治疗指征:平均CBFV≥120 cm/s,且在诱导性高血压下仍持续神经功能恶化或需插管。
  • 作者建议的分层:轻度症状性CV为CBFV<180 cm/s,难治性CV且严重CBFV升高为CBFV≥180 cm/s。

处置流程与药物剂量

  • 按原文描述:对药物治疗无反应的症状性CV,先实施SGB作为挽救治疗,难治时再升级为动脉内解痉(IAS),使用米力农。
  • 作者建议:轻度症状性CV(CBFV<180 cm/s)单用SGB;难治性CV且CBFV≥180 cm/s时升级IAS可能有益。

红旗征与不能漏的情况

  • 平均CBFV≥120 cm/s且在诱导性高血压下仍持续神经功能恶化或需插管,提示需启动挽救治疗。

研究设计与关键结果

  • 回顾性分析纳入82例患者(平均年龄50.16岁)、184个治疗区域,另设109个未受累区域对照。
  • 次日大脑中动脉平均CBFV下降:SGB组-30.1(±45.2)cm/s,IAS组-31.5(±45.2)cm/s。
  • 混合线性回归显示治疗类别有统计学意义;性别、年龄、动脉瘤治疗方式(夹闭或栓塞)、WFNS评分、Fisher评分等固定效应无统计学意义。
  • Logistic回归显示ICU出院前影像学脑梗死(34/82)与随访时不良结局(GOS≤3)显著相关。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对动脉瘤性蛛网膜下腔出血后症状性CV且平均CBFV≥120 cm/s、诱导性高血压下仍持续神经功能恶化或需插管的患者,可先实施SGB作为挽救治疗,难治时升级为IAS(米力农)。
  • 作者建议:轻度症状性CV(CBFV<180 cm/s)单用SGB;难治性CV且CBFV≥180 cm/s时升级IAS可能有益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: In patients with symptomatic cerebral vasospasm (CV) following aneurysmal subarachnoid hemorrhage who do not respond to medical therapy, urgent treatment escalation has been suggested to be beneficial for brain tissue at risk. In our routine clinical care setting, we implemented stellate ganglion block (SGB) as a rescue therapy with subsequent escalation to intraarterial spasmolysis (IAS) with milrinone for refractory CV.

METHODS: In this retrospective analysis from 2012 to 2021, patients with CV following aneurysmal subarachnoid hemorrhage who received an SGB or IAS were identified. Patients were assessed through neurological examination and transcranial Doppler. Rescue therapy was performed in patients with mean cerebral blood flow velocity (CBFV) ≥ 120 cm/s and persistent neurological deterioration/intubation under induced hypertension. Patients were reassessed after therapy and the following day. The Glasgow Outcome Scale was assessed at discharge and 6-month follow-up.

RESULTS: A total of 82 patients (mean age 50.16 years) with 184 areas treated with SGB and/or IAS met the inclusion criteria; 109 nonaffected areas were extracted as controls. The mean CBFV decrease in the middle cerebral artery on the following day was - 30.1 (± 45.2) cm/s with SGB and - 31.5 (± 45.2) cm/s with IAS. Mixed linear regression proved the significance of the treatment categories; other fixed effects (sex, age, aneurysm treatment modality [clipping or coiling], World Federation of Neurological Surgeons score, and Fisher score) were insignificant. In logistic regression, the presence of cerebral infarction on imaging before discharge from the intensive care unit (34/82) was significantly associated with unfavorable outcomes (Glasgow Outcome Scale ≤ 3) at follow-up.

CONCLUSIONS: Stellate ganglion block and IAS decreased CBFV the following 24 h in patients with CV. We suggest SGB alone for patients with mild symptomatic CV (CBFV < 180 cm/s), while subsequent escalation to IAS proved to be beneficial in patients with refractory CV and severe CBFV elevation (CBFV ≥ 180 cm/s).

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Wendel C, Oberhauser C, Schiff J, et al. Stellate Ganglion Block and Intraarterial Spasmolysis in Patients with Cerebral Vasospasm: A Retrospective Cohort Study. Neurocrit Care. 2023. PMID: 37498456. doi:10.1007/s12028-023-01762-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。